SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-24-016242
Filing Date
2024-05-13
Accepted
2024-05-13 16:14:35
Documents
1
Period of Report
2024-05-09

Document Format Files

Seq Description Document Type Size
1 FORM 4 rdgdoc.html 4  
1 FORM 4 rdgdoc.xml 4 3647
  Complete submission text file 0001437749-24-016242.txt   5242
Mailing Address 6801 N CAPITAL OF TEXAS HIGHWAY BUILDING 1; SUITE 300 AUSTIN TX 78731
Business Address 6801 N CAPITAL OF TEXAS HIGHWAY BUILDING 1; SUITE 300 AUSTIN TX 78731 512-501-2444
CASSAVA SCIENCES INC (Issuer) CIK: 0001069530 (see all company filings)

IRS No.: 911911336 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O XOMA, LTD. 2910 SEVENTH STREET BERKELEY CA 94710
Business Address
SCANNON PATRICK J MD PHD (Reporting) CIK: 0001222790 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41905 | Film No.: 24939221